Jesper F. Lau,Thomas Kruse,Lars Linderoth,Henning Thoegersen,Jacob Kofoed,Kirsten Dahl
申请号：
US15262450
公开号：
US20170051034A1
申请日:
2016.09.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to novel peptide compounds which have a protracted profile of action and improved solubility and stability, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity.
